dc.contributorBuitrago-Medina, Daniel-Alejandro
dc.contributorMotta Velasco, Angela María
dc.creatorAyala-Bernal, Diana
dc.creatorTique-Hilarión, Anyela
dc.date.accessioned2020-08-20T15:50:47Z
dc.date.accessioned2022-09-22T15:11:38Z
dc.date.available2020-08-20T15:50:47Z
dc.date.available2022-09-22T15:11:38Z
dc.date.created2020-08-20T15:50:47Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/28184
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3445850
dc.description.abstractBackground: Rising demand for aesthetic procedures has led to an increase in vascular complications such as blindness, necrosis and cerebral infarction. However, so far none study has compiled the body of evidence about these complications and its consequences. Methodology: This scoping review included studies that investigated or described vascular complications of facial injectable procedures until March 2020. We aimed to identify their main characteristics and possible associations. Results: A total of 108 publications were included, most of them case reports and small series. Blindness being the most frequent complication followed by necrosis, impending necrosis, cerebral infarction and alopecia. Likewise, hyaluronic acid injection was the most performed procedure followed by autologous fat injection and sclerotherapy. Conclusion: Numerous scientific publications have reported or described vascular events after aesthetic facial injections, many of them leading to blindness. Despite the low level of evidence found in the current literature, it is clear that facial injectables require skilled and trained medical professionals in facial anatomy, rheology, injection techniques and most importantly, recognition of early signs of impending necrosis and management of vascular complications.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Medicina Estética y laser
dc.publisherFacultad de Medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsRestringido (Temporalmente bloqueado)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.source1. Crerand CE, Menard W, Phillips KA. Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder. Ann Plast Surg. julio de 2010;65(1):11-6.
dc.sourceRayess HM, Svider PF, Hanba C, Patel VS, DeJoseph LM, Carron M, et al. A Cross-sectional Analysis of Adverse Events and Litigation for Injectable Fillers. JAMA Facial Plast Surg. 21 de diciembre de 2017.
dc.source3. plastic-surgery-statistics-report-2018.pdf [Internet]. Disponible en: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf
dc.source4. Emer J, Waldorf H. Injectable neurotoxins and fillers: there is no free lunch. Clin Dermatol. diciembre de 2011;29(6):678-90.
dc.source5. Townshend A. Blindness After Facial Injection. J Clin Aesthetic Dermatol. diciembre de 2016;9(12):E5-7.
dc.source6. Lee JI, Kang SJ, Sun H. Skin Necrosis with Oculomotor Nerve Palsy Due to a Hyaluronic Acid Filler Injection. Arch Plast Surg. julio de 2017;44(4):340-3.
dc.source7. Prado G, Rodríguez-Feliz J. Ocular Pain and Impending Blindness During Facial Cosmetic Injections: Is Your Office Prepared? Aesthetic Plast Surg. febrero de 2017;41(1):199-203.
dc.source8. Wang Q, Zhao Y, Li H, Li P, Wang J. Vascular Complications After Chin Augmentation Using Hyaluronic Acid. Aesthetic Plast Surg. 19 de diciembre de 2017.
dc.source9. Schelke LW, Fick M, van Rijn LJ, Decates T, Velthuis PJ, Niessen F. [Unilateral blindness following a non-surgical rhinoplasty with filler]. Ned Tijdschr Geneeskd. 2017;161(0):D1246.
dc.source10. Maruyama S. A Histopathologic Diagnosis of Vascular Occlusion After Injection of Hyaluronic Acid Filler: Findings of Intravascular Foreign Body and Skin Necrosis. Aesthet Surg J. 1 de octubre de 2017;37(9):NP102-NP108.
dc.source11. Safety Alerts for Human Medical Products > Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication - Risk of Serious Patient Injury [Internet]. [cited 2018 Apr 28]. Available from: https://wayback.archive-it.org/7993/20170406123714/https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm448439.htm
dc.source12. alertaHialuronicorevisadaiii.pdf [Internet]. [cited 2018 Apr 28]. Available from: https://www.invima.gov.co/images/pdf/tecnovigilancia/informes_seguridad/Alertas_internacionales_2015/alertaHialuronicorevisadaiii.pdf
dc.source13. Goodman GJ, Roberts S, Callan P. Experience and Management of Intravascular Injection with Facial Fillers: Results of a Multinational Survey of Experienced Injectors. Aesthetic Plast Surg. agosto de 2016;40(4):549-55.
dc.source14. Urdiales-Gerts S, Callan P. Experience and Management of Intravascular Injection withTreatment of Soft Tissue Filler Complications: Expert Consensus Recommendations. Aesthetic Plast Surg. 2018 Apr;42(2):498–510.
dc.source15. Fitzgerald R, Bertucci V, Sykes JM, Duplechain JK. Adverse Reactions to Injectable Fillers. Facial Plast Surg FPS. octubre de 2016;32(5):532-55.
dc.source16. Urdiales-Gt Surg FPS. octubre de 2016;32(5):532-55. aza JV, Mira M, Moreno A, et al. Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations. Aesthetic Plast Surg. 2018 Apr;42(2):498–510.a
dc.source17. Poljšak B., Dahmane R., Godic A. Intrinsic skin aging: The role of oxidative stress. Acta Dermatovenerol APA | 2012;21:1-4
dc.source18. Amano S. Characterization and mechanisms of photoageing-related changes in skin. Damages of basement membrane and dermal structures. Experimental Dermatology. 2016;25:14-19
dc.source19. Gilchrest B. Photoaging. J Invest Dermatol. 2013;1;133(E1):E2-6
dc.sourceEl-Domyati M, Attia S, Saleh F, Brown D, Birk D, Gasparro F et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Experimental Dermatology. 2002;11(5):398-405.
dc.source21. McDaniel D, Farris P, Valacchi G. Atmospheric skin aging-Contributors and inhibitors. Journal of Cosmetic Dermatology. 2018;17(2):124-137.
dc.source22. Weissler J, Carney M, Carreras Tartak J, Bensimon R, Percec I. The Evolution of Chemical Peeling and Modern-Day Applications. Plastic and Reconstructive Surgery. 2017;140(5):920-929.
dc.sourceWulc AE, Sharma P, Czyz CN. The anatomic basis of midfacial aging. En: Harstein ME, Wulc AE, Holch DE (eds) Midfacial rejuvenation. Springer, Heidelberg; 2012: 15–28
dc.source24. Mammucari M, Gatti A, Maggiori S, Bartoletti CA, Sabato AF. Mesotherapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy. Eur Rev Med Pharmacol Sci. junio de 2011;15(6):682-94.
dc.source25. Lee JC, Daniels MA, Roth MZ. Mesotherapy, Microneedling, and Chemical Peels. Clin Plast Surg. julio de 2016;43(3):583-95.
dc.source26. Afrooz PN, Pozner JN, DiBernardo BE. Noninvasive and minimally invasive techniques in body contouring. Clin Plast Surg. octubre de 2014;41(4):789-804.
dc.source27. Duncan D, Rotunda AM. Injectable therapies for localized fat loss: state of the art. Clin Plast Surg. julio de 2011;38(3):489-501, vii.
dc.source28. Jayasinghe S, Guillot T, Bissoon L, Greenway F. Mesotherapy for local fat reduction. Obes Rev Off J Int Assoc Study Obes. octubre de 2013;14(10):780-91.
dc.source29. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. abril de 2006;32(4):465-80.
dc.source30. Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A. Botulinum Toxin Off-Label Use in Dermatology: A Review. Skin Appendage Disord. marzo de 2017;3(1):39-56
dc.source31. de Maio M, DeBoulle K, Braz A, Rohrich RJ, Alliance for the Future of Aesthetics Consensus Committee. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Midface. Plast Reconstr Surg. octubre de 2017;140(4):540e-550e.
dc.source32. Giordano CN, Matarasso SL, Ozog DM. Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies. J Am Acad Dermatol. junio de 2017;76(6):1027-42.
dc.source33. França K, Kumar A, Fioranelli M, Lotti T, Tirant M, Roccia M. The history of Botulinum toxin: from poison to beauty. Wiener Medizinische Wochenschrift. 2017;167(S1):46-48.
dc.source34. Ozturk C, Li Y, Tung R, Parker L, Piliang M, Zins J. Complications Following Injection of Soft-Tissue Fillers. Aesthetic Surgery Journal. 2013;33(6):862-877.
dc.source35. Cox S, Adigun C. Complications of injectable fillers and neurotoxins. Dermatologic Therapy. 2011;24(6):524-536.
dc.source36. Walker K, Pellegrini MV. Hyaluronic Acid. [Updated 2018 Jan 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan.
dc.sourceGreeneJ et Al. The Hyaluronic Acid Fillers. Current Understanding of the Tissue Device Interface. Facial Plast Surg Clin N Am. 2015; 23: 423–432
dc.source38. Hersant, J.P. Meningaud. Hyaluronic acid rheology: Basics and clinical applications in facial rejuvenation. Annales de chirurgie plastique esthétique. 201762, 261—267
dc.source39. Kadouch J. Calcium hydroxylapatite: A review on safety and complications. Journal of Cosmetic Dermatology. 2017;16(2):152-161.
dc.source40. Tracy L, Ridgway J, Nelson J, Lowe N, Wong B. Calcium hydroxylapatite associated soft tissue necrosis: A case report and treatment guideline. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2014;67(4):564-568.
dc.source41. Pavicic T. Calcium hydroxylapatite filler: an overview of safety and tolerability. J Drugs Dermatol. 2013,12(9):996-1002.
dc.source42. Rotunda A, Narins R. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatologic Therapy. 2006;19(3):151-158.
dc.source43. Lee J, Lorenc Z. Synthetic Fillers for Facial Rejuvenation. Clinics in Plastic Surgery. 2016;43(3):497-503
dc.source44. de Melo F, Nicolau P, Piovano L, Lin SL, Baptista-Fernandes T and cols. Recommendations for volumen augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clin Cosmet Investig Dermatol. 2017:10 431–440
dc.source45. Pallua N, Wolter T, Markowicz M. Platelet-rich plasma in burns. Burns. 2010;36(1):4-8.
dc.source46. Elghblawi E. Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering. Journal of Cosmetic Dermatology. 2017: 1-8.
dc.source47. Chiang Y, Pierone G, Al-Niaimi F. Dermal fillers: pathophysiology, prevention and treatment of complications. Journal of the European Academy of Dermatology and Venereology. 2016;31(3):405-413.
dc.source48. Levy LL, Emer JJ. Complications of minimally invasive cosmetic procedures: prevention and management. J Cutan Aesthetic Surg. abril de 2012;5(2):121-32.
dc.source49. DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J. 1 de mayo de 2014;34(4):584-600.
dc.source50. Cohen JL, Biesman BS, Dayan SH, et al. Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations. Aesthet Surg J. 2015;35(7):844‐849.
dc.source51. Henderson R, Reilly DA, Cooper JS. Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues. Plast Reconstr Surg Glob Open. 2018;6(1):e1618.
dc.source52. Van Loghem J, Funt D, Pavicic T, et al. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus [published online ahead of print, 2020 Mar 17]. J Cosmet Dermatol. 2020.
dc.sourceKalyam K, Kavoussi S, Ehrlich M, Teng C, Chadha N, Khodadadeh S et al. Irreversible Blindness Following Periocular Autologous Platelet-Rich Plasma Skin Rejuvenation Treatment. Ophthalmic Plastic and Reconstructive Surgery. 2017;33:S12-S16.
dc.source54. Loh KT, Chua JJ, Lee HM, et al. Prevention and management of vision loss relating to facial filler injections. Singapore Med J. 2016;57(8):438‐443.
dc.source55. Carruthers J, Fagien S, Dolman P. Retro or PeriBulbar Injection Techniques to Reverse Visual Loss After Filler Injections. Dermatol Surg. 2015;41 Suppl 1:S354‐S357.
dc.source56. Jones, Jill K. Bennett, Sharon Erlandsson, et al. Aesthetic Medicine Nurses and Qualified Nonmedical Practitioners: Our Role and Requirements as Aesthetic Medicine Adapts to Worldwide Changes and Needs, Plastic Surgical Nursing: October/December 2018 - Volume 38 - Issue 4 - p 153-157
dc.source57. Helena Collier, Nurses with inadequate skills should not be practising aesthetic medicine. Journal of Aesthetic Nursing 2018 7:6, 322-323
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectRellenos dérmicos
dc.subjectProcedimientos estéticos faciales inyectables
dc.subjectEventos adversos
dc.subjectComplicaciones vasculares
dc.subjectCeguera
dc.subjectNecrosis
dc.subjectNecrosis inminente
dc.titleComplicaciones vasculares de procedimientos estéticos faciales inyectables: revisión de alcance
dc.typemasterThesis


Este ítem pertenece a la siguiente institución